EraCal Therapeutics Ltd.

The biotech-company EraCal Therapeutics Ltd. is a spin-off from the University of Zurich and Harvard University. The company is privately held by a biotech-specialized investor base incl. BERNINA BioInvest, Redalpine, and UZH Life Sciences Fund.

 

Founders

Bild_Josua_2016.jpg

J. Jordi Ph.D.

Chief Executive Officer & Board Member

Josua Jordi is a biochemist ETH by training and completed a Ph.D. in physiology at the University of Zurich. He developed EraCal’s platform as a postdoctoral fellow at Harvard University.

Bild_Simon_2019.png

S. Breitler Ph.D.

Chief Operational Officer

Simon Breitler holds a Ph.D. in synthetic organic chemistry from ETH Zurich which was complemented with a fellowship at Harvard University. He previously led a team in preclinical chemistry, manufacturing, and control (CMC) department at Roche.

 

Board of Directors

Ann1_2021.jpg

A. Kessler Ph.D.

Chairman

Ann Kessler held various senior research positions at Roche for over 26 years. She launched the obesity research program, led its clinical development, and brought orlistat (Alli, Xenical) to the market.

Cossery.png

JM. Cosséry Ph.D.

Board Member

Jean-Michel Cosséry is a senior healthcare executive with global leadership experience in research, biotech, and commercial roles within Eli Lilly, GE Healthcare, Kymab Ltd, Immunocore Ltd. among others.

Hamilton.jpg

GK. Hamilton

Board Member

Gregory K. Hamilton is CEO of Epigenomics AG and has over 20 years of management experience in molecular diagnostics, manufacturing, and professional service industries.

Bettina.png

B. Ernst Ph.D.

Board Member

Bettina Ernst is a biotech entrepreneur and investor. She serves the Swiss Biotech community in various roles thanks to her deep experience in medical research in the US and Europe.

 

Scientific Advisory Board

Foto Henning B SAB.jpg

H. Böttcher Ph.D.

Henning Böttcher is the former head of medicinal chemistry at Merck KGaA.

florian_engert.jpg

Prof. F. Engert

Florian Engert is a neuroscience expert and tenured professor at Harvard University.

Meyer Druck.jpg

G. Meyer Ph.D.

Gerd Meyer is Head of Plexus Ventures CH, a leading global development & licensing firm.

lutz.jpg

Prof. T. A. Lutz

Thomas A. Lutz is an obesity and diabetes expert and tenured professor at the University of Zurich.

12_01_T_Weller_0010 - Copy.jpg

T. Weller Ph.D.

Thomas Weller is the former head of medicinal chemistry at Idorsia/Actelion.